Does diabetes impact therapeutic immunomodulation therapy decisions for kidney transplant recipients? Data from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) trial
International Journal of Nephrology and Renovascular Disease | Aug 31, 2017
Most read this week